Ashtons creates two respiratory clinical toolkits for COPD and Asthma

 In Ashtons News, Conditions, Developing your Team, New Product, Training

Asthma is a long-term condition characterised by paroxysmal and reversible obstruction of the airways, whereas Chronic Obstructive Pulmonary Disease (COPD) is a chronic, not fully reversible condition, which results in obstructed airflow to the lungs. There are 5.4 million people in the UK that receive treatment for asthma and an estimated 1.2 million people are living with diagnosed COPD. Making these two of the most common lung diseases, respectively.

Respiratory symptoms are common in the mental health patient population due to increased levels of smoking of tobacco and use of illicit substances. Non-compliance is also common in patients with mental health issues and can worsen respiratory conditions. Increased BMI can also contribute to respiratory problems. Furthermore, patients diagnosed with asthma/COPD (especially if uncontrolled) have a higher prevalence of depression and anxiety.

In the midst of the COVID-19 pandemic and with the flu season upon us, it is more important than ever to ensure that every patient who has been previously diagnosed with either asthma or COPD is not only being treated appropriately but also is compliant with their prescribed therapeutic regime.

In order to help you achieve this, Ashtons have developed two respiratory clinical toolkits; one on COPD and one on asthma.

These guides give you a basic overview of the two main respiratory illnesses as well as providing guidance on diagnosing and monitoring the diseases. The main aim is to improve the accuracy of diagnosis, as well as advice on how to help patients control their conditions using an evidence base for the long-term management of asthma and COPD along with treatment options for acute exacerbations. The management of both include both pharmacological and non-pharmacological interventions.

The information provided is up to date and takes into account the most recent NICE guidelines (including NG80 – updated in February 2020), as well as the BTS/SIGN guidelines. Both toolkits are available from your Visiting Pharmacists.

In addition to these guides, we will be launching a new Ashtons training seminar on Asthma and COPD in early 2021 to complement our current educational suite available for training seminars. In comparison to the toolkits this training seminar begins with the causes, triggers and symptoms of asthma and COPD. It goes on to provide detailed information on the drugs available for the treatment and management of the conditions, in a step-wise approach. This is an invaluable topic that will be of interest to many, especially those that have patients who are affected by either of the respiratory illnesses. Please contact your visiting pharmacist to schedule this training session onsite or via video conference if you prefer.

Recent Posts

Start typing and press Enter to search